# Regentis Biomaterials Ltd. (RGNT)

> Source: Nexqual · https://nexqual.com/RGNT · data as of 2026-10-23 19:59 UTC · cite as "Nexqual, Regentis Biomaterials Ltd. (RGNT), nexqual.com/RGNT" · informational, not investment advice.

**Price:** USD 1.28 (-8.57% on the day) · last close of Oct 23, 2026; US market closed, not a live price. Prev close 1.4 · day 1.28–1.42 · 52w 1.23–15.5 · market cap $9.0M · ASE

## Key facts
- Analysts: None (1 analysts), mean target USD 10 (range 10–10).
- Total return with dividends: 1Y -82.9% vs S&P 500 +13.4%; 5Y -82.9% vs S&P 500 +76.9%.

## Analysts
Consensus None, 1 analysts; mean target USD 10 (low 10, high 10).

## Total return (dividends reinvested)
|  | 1Y (from 2025-12-04) | 5Y (from 2025-12-01) |
|---|---|---|
| Total return | -82.9% | -82.9% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | — | — |
| Volatility (annualized) | 239.6% | 142.7% |
| Max drawdown | -86.4% (Jun 2026→Oct 2026) | -82.9% (Dec 2025→Oct 2026) |

## Peers (Medical Instruments & Supplies)
KMTS (Kestra Medical Technologies, Lt) USD 28.76 +1.55% · XRAY (DENTSPLY SIRONA Inc.) USD 9.43 -0.74% · LMAT (LeMaitre Vascular, Inc.) USD 84.45 -1.03% · ATRC (AtriCure, Inc.) USD 58.97 -0.56% · WRBY (Warby Parker Inc.) USD 25.91 +0.93% · PLSE (Pulse Biosciences, Inc) USD 53.02 +0.65%

## More
Full page: https://nexqual.com/RGNT · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Supply chain and relationships (SEC annual reports)

Named in RGNT's own 20-F filed 2026-02-24 (https://www.sec.gov/Archives/edgar/data/1912966/000121390026019917/ea0277515-20f_regentis.htm):

| Relationship | Company | Sentence in the filing |
|---|---|---|
| Supplier | Baxter Healthcare | "July 24, 2008, we entered into a supply agreement, or the Supply Agreement, with Baxter Healthcare Corporation, or Baxter, and Teva Medical" |

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-03-31) | — | — | — | $0 | — |
| Next quarter | — | — | — | $0 | — |
| Current fiscal year (ends 2026-12-31) | $-0.68 | $0.00 | — | $0 | 1 |
| Next fiscal year (ends 2027-12-31) | — | — | — | $0 | — |